[Photo: Irina Gutyryak/iStock]
Corganics, formerly MD Farma, aims to bring a higher quality, more transparent product portfolio to the CBD market. The investment from Dallas-based Altacrest Capital is meant to propel the team into its next growth phase, fulfilling the mission to "deliver effective clinical cannabinoid products that healthcare professionals and their patients can trust."